(Q38449116)

3 September 2017

title

High-throughput determination of mode of inhibition in lead identification and optimization (English)

1 reference

3 September 2017

5

Alexander Margulis

1 reference

3 September 2017

Min Wei

1

1 reference

3 September 2017

Richard Wynn

2

1 reference

3 September 2017

Gregory Hollis

3

1 reference

3 September 2017

Boshan Liao

4

1 reference

3 September 2017

Brian G Reid

6

1 reference

3 September 2017

Ronald Klabe

7

1 reference

3 September 2017

Phillip C C Liu

8

1 reference

3 September 2017

Mary Becker-Pasha

9

1 reference

3 September 2017

Mark Rupar

10

1 reference

3 September 2017

Timothy C Burn

11

1 reference

3 September 2017

Dale E McCall

12

1 reference

3 September 2017

Yanlong Li

13

1 reference

3 September 2017

publication date

1 March 2007

1 reference

Journal of Biomolecular Screening

3 September 2017

published in

1 reference

3 September 2017

volume

12

1 reference

3 September 2017

issue

2

1 reference

3 September 2017

page(s)

220-228

1 reference

Designing screens: how to make your hits a hit.

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1087057106296679

Hit and lead generation: beyond high-throughput screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106296679

Mechanistic considerations in high-throughput screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106296679

A Common Mechanism Underlying Promiscuous Inhibitors from Virtual and High-Throughput Screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106296679

Identification and Prediction of Promiscuous Aggregating Inhibitors among Known Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106296679

Kinase inhibitors: not just for kinases anymore

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106296679

A non-ATP-competitive inhibitor of BCR-ABL overrides imatinib resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106296679

Structure-based design and discovery of protein tyrosine phosphatase inhibitors incorporating novel isothiazolidinone heterocyclic phosphotyrosine mimetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106296679

Potent benzimidazole sulfonamide protein tyrosine phosphatase 1B inhibitors containing the heterocyclic (S)-isothiazolidinone phosphotyrosine mimetic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106296679

Homogeneous proximity tyrosine kinase assays: scintillation proximity assay versus homogeneous time-resolved fluorescence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106296679

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106296679

A specific mechanism of nonspecific inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106296679

Recent progress in development of non-ATP competitive small-molecule inhibitors of protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106296679

A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106296679

21 January 2018

Identifiers

DOI

10.1177/1087057106296679

1 reference

3 September 2017

1 reference